Lilly breaks ground on $6.5B Houston plant for Foundayo
Eli Lilly broke ground in Houston to expand factory capacity for Foundayo, its newly launched obesity pill, and CEO Dave Ricks said the drug has won one-third of new GLP-1 pill starts. The company is also targeting market share versus Novo Nordisk in oral obesity drugs.